The largest blog for reading the latest medical research on all disease, the prevention and its treatment . Pulled from variety of sources

Thursday, November 17, 2016

Palbociclib can help slow advanced breast cancer : cbsnews





As it stated in cbsnews

Palbociclib can help slow advanced breast cancer

Palbociclib can help slow advanced breast cancer
Palbociclib can help slow advanced breast cancer
A recently approved drug can help slow the progression of advanced breast cancer, a new clinical trial confirms.The drug, called palbociclib (Ibrance), was approved in the United States last year for treating advanced cases of ER-positive breast cancer.That means the cancer uses the hormone estrogen to help fuel its growth.The approval was based on an earlier-stage study where the drug, used along with a standard drug called letrozole (Femara), helped keep women's cancer at bay.


let alone cbsnews

Do-it-yourself breast reconstruction device gives breast cancer patients more control

Do-it-yourself breast reconstruction device gives breast cancer patients more control
Do-it-yourself breast reconstruction device gives breast cancer patients more control
A new device is being tested by some breast cancer patients and their doctors that would allow women to participate in part of their own breast reconstruction process at home.It aims to make treatment more comfortable and convenient, but also to give a woman a greater sense of control — something breast cancer often takes away.More than 100,000 women each year in the United States have surgery to remove a cancerous breast, and many of them choose reconstruction with an implant.To make room for a permanent one, many use a tissue expander, a temporary pouch that is gradually enlarged with saline to stretch the remaining skin and muscle of the breast.


not to mention dailymail

NHS to offer first new breast cancer drug for a decade

NHS to offer first new breast cancer drug for a decade
NHS to offer first new breast cancer drug for a decade
The Health Service is to prescribe its first new drug to defeat breast cancer in a decade following a funding U-turn yesterday.The rationing watchdog NICE had refused to approve Perjeta, which wipes out an aggressive breast cancer in 40 per cent of cases, but had a change of heart after pharmaceutical firm Roche cut the price.An estimated 1,380 women a year in England and Wales will benefit from the drug, which is given to patients with the HER2-positive form of breast cancer as soon as they are diagnosed.It is taken every three weeks through a drip in combination with the drug Herceptin and standard chemotherapy, usually for 12 weeks, when tumours can be surgically removed.


No comments:

Post a Comment